Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Case Report

Progressive hypoventilation due to mixed CD8⁺ and CD4⁺ lymphocytic polymyositis following tremelimumab - durvalumab treatment

Online download statistics by month:

Online download statistics by month: December 2019 to December 2022

	Abstract	Full	Pdf
Dec 2019	5	5	0
Jan 2020	6	6	1
Feb 2020	5	5	3
Mar 2020	18	18	2
Apr 2020	7	7	4
May 2020	26	26	6
Jun 2020	16	16	0
Jul 2020	20	20	10
Aug 2020	5	5	2
Sep 2020	23	23	7
Oct 2020	18	18	2
Nov 2020	18	18	5
Dec 2020	15	15	5
Jan 2021	12	12	2
Feb 2021	11	11	3
Mar 2021	18	18	6
Apr 2021	14	14	2
May 2021	12	12	6
Jun 2021	12	12	5
Jul 2021	12	12	3
Aug 2021	10	10	3
Sep 2021	17	17	3
Oct 2021	17	18	6
Nov 2021	17	17	3
Dec 2021	18	20	6
Jan 2022	10	11	2
Feb 2022	17	17	1
Mar 2022	20	20	2
Apr 2022	17	18	9
May 2022	33	33	1
Jun 2022	29	29	0
Jul 2022	20	21	1
Aug 2022	32	32	5
Sep 2022	26	26	1
Oct 2022	30	30	7
Nov 2022	31	33	11
Dec 2022	13	13	0
Total	630	638	135